References
- Billingham M EJ. Cytokines as inflammatory mediators. Br Med But 1987; 43: 350–370
- Dinarello C A. Cytokines: Interleukin-1 and tumour necrosis factor (Cachectin). Inflammation: Basic Principles and Clinical Correlates, J. I. Gallin, I. M. Goldstein, R. Synderman. Raven Press Ltd, New York 1988; 195–208
- Berridge M J, Irvine R F. Inositol phosphates and cell signalling. Nature 1989; 341: 107–205
- Wijelath E S, Kardasz A M, Drummond R, Watson J. Interleukin-1 induced inositol phospholipid breakdown of murine macrophages; possible mechanism of receptor activation. Biochem Biophys Res Com 1988; 152: 392–397
- Mochan E, Rashatwar M. Interleukin-1 stimulates inositol phosphate turnover in human synovial cells in culture. Arth Rheum 1988; 31: S49, Abs. 71
- Dinarello C A. Interleukin-1. Rev Infect Dis 1984; 6: 51–95
- McKean M L, Smith J B, Silver J M. Formation of lysophos-phatidyl choline by human platelets in response to thrombin. Support for the phospholipase A, pathway for the liberation of arachidonic acid. J Biol Chem 1982; 256: 1522–1524
- Berridge M J. Inositol trisphosphate and diacyl-glycerol as second messengers. Biochem J 1984; 220: 345–360
- Chang J, Oilman S L, Lewis A L. Interleukin-1 activates phospholipase A, in rabbit chondrocytes: A possible signal for IL-1 action. J Immunol 1986; 136: 1283–1287
- Harvey W, McGhji S. Prostaglandins in pathological bone resorption. Agents Actions 1986; 19: 73–79
- Schyder J. Payne T. Effect of interleukin-1 and -2 on enzyme secretion and prostaglandin formation by chondrocytes. Br J Rheumatol 1985; 24: 128–132
- Watson J, Chuah S Y. Prostaglandins, steroids and human mammary cancer. Eur J Cane Clin Oncol 1985; 21: 1051–1055
- Emilsson A, Sundler R. Studies on the enzymatic pathyways of calcium ionophorc-induccd phospholipid degradation and arachidonic acid mobilization in peritoneal macrophages. Biochim Biophys Acta 1985; 846: 265–274
- Oilman S C, Chang J, Zeigler R R, Uhl J, Mochan E. Inter-leukin-1 activates phospholipase A, in human synovial cells. Arth Rheum 1988; 31: 126–130
- Dayer J M, Goldring S R, Robinson D R, Krane S M. Effects of human mononuclear cell factor on cultured rheumatoid synovial cells. Interactions of prostaglandins E-, and cyclic adenosine 3′,5′ monophosphate. Biochem Biophys Acta 1979; 586: 87–105
- Nakashima S, Suganuma S, Sato M, Tohamatsu T, Nozawa Y. Mechanism of arachidonic acid liberation in platelet-activating-factor-stimulated human polymorpho-nuclear neutrophils. J Immunol 1989; 143: 1295–1302
- Bonney R J, Humes J L. Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages. J Leuk Biol 1984; 35: 1–10
- Hirata F, Schiffman E, Venkatasubramaniam K, Salomon D. Axelrod J. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Nat Acad Sci USA 1980; 77: 2533–2536
- Hirata F. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem 1981; 256: 7730–7733
- Touqui L, Rothat B, Shaw A M, Fradin A, Vargaftig B B. Platelet activation-a role for a 40K. anti-phospholipase A, protein indistinguishable from lipocorti. Nature 1986; 321: 177–180
- Billah M M, Lapctina E G. Formation of lysophosphatidylino-sitol in platelets stimulated with thrombin or lonophorc A23I87. J Biol Chem 1982; 257: 54196–5200
- Burch R M, Connor J R, Axelrod J. lnlerleukin-1 amplifies receptor-mediated activation of phospholipase A, in 3T3 fibroblasts. Proc Natl Acad Sci USA 1988; 85: 6306–6309
- Gonzalez-Buriticia H, Smith D M, Turner R A. Characterisation of soluble and cell associated phospholipase A, from reheumatoid synovial fluid. Annals Rheum Dis 1989; 48: 557–564